Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | HUM | Humana Common | 182 | Apr 1, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | HUM | Options | 3,086 | Apr 1, 2023 | Humana Common | 3,086 | $430.62 | Direct | F1 | |||||
holding | HUM | Options | 2,838 | Apr 1, 2023 | Humana Common | 2,838 | $510.24 | Direct | F2 | |||||
holding | HUM | Restricted Stock Units | 523 | Apr 1, 2023 | Humana Common | 523 | Direct | F3, F4 | ||||||
holding | HUM | Restricted Stock Units | 735 | Apr 1, 2023 | Humana Common | 735 | Direct | F3, F5 |
Andrew C. Agwunobi M.D. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25. |
F2 | Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. |
F3 | Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). |
F4 | Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
F5 | Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. |